Tenderwize
Back to tender search

Discount agreements for triptorelin medicines

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Jan 31, 2027 · 72 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Triptorelin, ATC L02AE04, H01CA07

53/100

Opportunity Score

Needs reviewHigh complexity
SuppliesOpen
Why this score?

Opportunity

53 / 100

Complexity

67 / 100

Risk factors

The notice provides no value, volume, minimum purchase, or demand information, so the commercial return cannot be asses...

The buyer may replace the open-house agreements with exclusive rebate agreements, causing the open-house contracts to e...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Jan 31, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Mar 2027
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Sections 130a(8) and 130c(1) SGB V for medicines containing Triptorelin.
  • Coverage of ATC classifications L02AE04 and H01CA07.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreements offered by AOK Rheinland-Pfalz/Saarland for Triptorelin (ATC L02AE04 and H01CA07) in Germany. Eligible pharmaceutical companies may join under uniform, non-negotiable conditions without a competitive selection decision. Contracts may be concluded monthly through the maximum 24-month period, but may end automatically if replaced by exclusive rebate agreements. No contract value is provided. Procurement documents were not included in the extracted text and must be obtained from the buyer.

Risks

The notice provides no value, volume, minimum purchase, or demand information, so the commercial return cannot be asses...

The buyer may replace the open-house agreements with exclusive rebate agreements, causing the open-house contracts to e...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorised and marketable medicines in Germany may be supplied.

Administrative

  • Where the medicine is not yet shown as marketable in Lauer-Taxe, evidence from the public AMIce database must be submitted for each relevant medicine.
  • The evidence must identify the medicine, authorisation holder or other legally authorised pharmaceutical entrepreneur and basis of authorisation, pharmaceutical form, active...

Buyer

Lots (1)

LOT-0001

Triptorelin pharmaceutical rebate agreements

Non-exclusive rebate agreements for authorised and marketable Triptorelin medicines in Germany. The open-house model permits participation by all interested pharmaceutical companies meeting the stated requirements, with no individual negotiations. Children’s medicines listed under the relevant BfArM list are excluded.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Mar 2025 - Mar 2027

Category

Pharmaceutical products

Deadline

Deadline Jan 31, 2027

Procurement Details

Publication date
09 Feb 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
88325-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy